Ampio Pharmaceuticals logo
Ampio Pharmaceuticals AMPE
$ 0.62 -11.43%

Ampio Pharmaceuticals Balance Sheet 2011-2024 | AMPE

Annual Balance Sheet Ampio Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-12 M -33 M -16.1 M -5.06 M -7.59 M -8.21 M -4.89 M -22 M -50.3 M -26.3 M -17.7 M -11.4 M

Long Term Debt

- 274 K 614 K - - - - - 4.92 M - - - -

Long Term Debt Current

274 K 340 K 311 K 284 K 259 K - - - - - - - -

Total Non Current Liabilities

- - - 3.53 M 3.27 M 7.41 M 45.6 M 4.83 M 6.98 M 1.13 M 331 K 381 K 431 K

Total Current Liabilities

2.38 M 1.19 M 5.12 M 1.83 M 4.28 M 1.38 M 3.88 M 2.13 M 5.52 M 3.68 M 2.47 M 1.64 M 1.29 M

Total Liabilities

2.38 M 1.8 M 11.5 M 5.37 M 7.56 M 8.79 M 49.5 M 6.96 M 12.5 M 4.81 M 2.8 M 2.02 M 1.72 M

Deferred Revenue

- - - - - - - - 85.7 K 85.7 K 50 K 50 K 50 K

Retained Earnings

-243 M -234 M -218 M -201 M -185 M -171 M -205 M -153 M -134 M -102 M -63.8 M -39.8 M -28.2 M

Total Assets

5.74 M 13.6 M 38.8 M 22.9 M 14 M 14 M 15.3 M 13.6 M 50.4 M 70.3 M 36 M 25.8 M 19.5 M

Cash and Cash Equivalents

4.09 M 12.7 M 33.9 M 17.3 M 6.53 M 7.59 M 8.21 M 4.89 M 16 M 50.3 M 26.3 M 17.7 M 11.4 M

Book Value

3.36 M 11.8 M 27.3 M 17.5 M 6.44 M 5.24 M -34.2 M 6.63 M 37.9 M 65.5 M 33.2 M 23.8 M 17.8 M

Total Shareholders Equity

3.36 M 11.8 M 27.3 M 17.5 M 6.44 M 5.24 M -34.2 M 6.63 M 37 M 66.1 M 33.1 M 23.8 M 17.8 M

All numbers in USD currency

Quarterly Balance Sheet Ampio Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 94 K 185 K 274 K 362 K 448 K 533 K 614 K 694 K 773 K 851 K 925 K 925 K 925 K 925 K 1.21 M 1.28 M 1.21 M 1.21 M 477 K - 477 K 477 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 6.98 M - - - - - - - - - - - - - - - - - - -

Total Liabilities

2.27 M 2.59 M 2.86 M 1.8 M 4.99 M 7.12 M 10.5 M 11.5 M 5.2 M 6.35 M 4.95 M 5.37 M 5.37 M 5.37 M 5.37 M 7.56 M 7.56 M 7.56 M 7.56 M 8.79 M 8.79 M 8.79 M 8.79 M 49.5 M 49.5 M 49.5 M 49.5 M 6.96 M 6.96 M 6.96 M 6.96 M 12.5 M 12.5 M 12.5 M 12.5 M 4.81 M 4.81 M 4.81 M 4.81 M 2.8 M 2.8 M 2.8 M 2.8 M 2.02 M 2.02 M 2.02 M 2.02 M 1.72 M 1.72 M 1.72 M 1.72 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 85.7 K 85.7 K 85.7 K 85.7 K 85.7 K 85.7 K 85.7 K 85.7 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K 50 K

Retained Earnings

-240 M -239 M -238 M -234 M -232 M -225 M -223 M -218 M -211 M -208 M -204 M -201 M -201 M -201 M -201 M -185 M -185 M -185 M -185 M -171 M -171 M -171 M -171 M -205 M -205 M -205 M -205 M -153 M -153 M -153 M -153 M -134 M -134 M -134 M -134 M -102 M -102 M -102 M -102 M -63.8 M -63.8 M -63.8 M - - - - - - - - -

Total Assets

7.65 M 9.15 M 10.7 M 13.6 M 18.8 M 27.2 M 32.8 M 38.8 M 22.5 M 26.7 M 21.7 M 22.9 M 22.9 M 22.9 M 22.9 M 14 M 14 M 14 M 14 M 14 M 14 M 14 M 14 M 15.3 M 15.3 M 15.3 M 15.3 M 13.6 M 13.6 M 13.6 M 13.6 M 50.4 M 50.4 M 50.4 M 50.4 M 70.3 M 70.3 M 70.3 M 70.3 M 36 M 36 M 36 M 36 M 25.8 M 25.8 M 25.8 M 25.8 M 19.5 M 19.5 M 19.5 M 19.5 M

Cash and Cash Equivalents

6.4 M 6.95 M 10.4 M 12.7 M 16.9 M 22.9 M 28.8 M 33.9 M 17.1 M 20.5 M 15.8 M 17.3 M 17.3 M 17.3 M 17.3 M 6.53 M 6.53 M 6.53 M 6.53 M 7.58 M 7.59 M 7.59 M 7.59 M 8.21 M 8.21 M 8.21 M 8.21 M 4.89 M 4.89 M 4.89 M 4.89 M 27 M 16 M 16 M 16 M 50.3 M 50.3 M 50.3 M 50.3 M 26.3 M 26.3 M 26.3 M 26.3 M 17.7 M 17.7 M 17.7 M 17.7 M 11.4 M 11.4 M 11.4 M 11.4 M

Book Value

5.38 M 6.56 M 7.88 M 11.8 M 13.8 M 20.1 M 22.3 M 27.3 M 17.3 M 20.4 M 16.8 M 17.5 M 17.5 M 17.5 M 17.5 M 6.44 M 6.44 M 6.44 M 6.44 M 5.24 M 5.24 M 5.24 M 5.24 M -34.2 M -34.2 M -34.2 M -34.2 M 6.63 M 6.63 M 6.63 M 6.63 M 37.9 M 37.9 M 37.9 M 37.9 M 65.5 M 65.5 M 65.5 M 65.5 M 33.2 M 33.2 M 33.2 M 33.2 M 23.8 M 23.8 M 23.8 M 23.8 M 17.8 M 17.8 M 17.8 M 17.8 M

Total Shareholders Equity

5.38 M 6.56 M 7.88 M 11.8 M 13.8 M 20.1 M 22.3 M 27.3 M 17.3 M 20.3 M 16.8 M 17.5 M 17.5 M 17.5 M 17.5 M 6.44 M 6.44 M 6.44 M 6.44 M 5.24 M 5.24 M 5.24 M 5.24 M -34.2 M -34.2 M -34.2 M 5 M 6.63 M 9.77 M 13.1 M 17.9 M 37 M 37 M 37 M 37 M 66.1 M 66.1 M 66.1 M 66.1 M 33.1 M 33.1 M 33.1 M 33.1 M 23.8 M 23.8 M 23.8 M 23.8 M 17.8 M 17.8 M 17.8 M 17.8 M

All numbers in USD currency